세계의 비수술 코성형 시장 규모, 점유율 및 동향 분석 보고서 : 필러 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Non-surgical Rhinoplasty Market Size, Share & Trends Analysis Report By Filler Type (HA Filler, CaHa Filler), By Application (Convex Nose, Others), By End Use (MedSpa, HCP-owned Clinic), By Region And Segment Forecasts, 2023 - 2030

US $ 5,950 ￦ 8,269,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,659,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,438,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

비수술 코성형 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 비수술적 라이노플라스틱 시장 규모는 CAGR 8.1%로 2030년까지 13억 달러에 달할 것으로 예상됩니다.

리퀴드 코 성형술로도 알려진 비수술적 코 성형술은 히알루론산 필러와 같은 주사 가능한 필러를 사용하여 사람의 코 모양을 변경하고 코를 선명하게 만드는 데 사용되는 비침습적 미용 성형술입니다. 이 방법은 즉각적인 효과가 있고, 다운타임이 없고, 덜 침습적이며, 비용이 저렴합니다. 이러한 모든 요인들이 시장 성장을 가속할 것으로 예상됩니다.

비수술적 코 성형술은 콧등 융기, 코의 비대칭, 콧대 오목, 코다리 함몰, 변형을 개선/위장하거나 경미한 휜 코를 치료할 때 시행할 수 있습니다. 그러나 이 수술은 코의 결함을 매끄럽게 하고 작은 대칭 문제를 해결하기 위해 수행되며, 큰 코의 결함을 치료할 수 없습니다.

HA 필러 및 CaHa 필러와 같은 주입식 필러는 액체 코 성형술에 가장 일반적으로 사용됩니다. 그러나 Medical News Today에 따르면 HA 필러는 성형외과 의사들이 널리 선호하고 채택하고 있습니다. 이는 이러한 필러가 생체 적합성, 자연스러운 느낌, 명확한 모양을 제공하고 합병증은 히알루로니다제 주사를 사용하여 되돌릴 수 있기 때문입니다.

2020년 2분기와 3분기에 코로나19의 대유행으로 인해 시장은 큰 후퇴를 겪었습니다. 그러나 비침습적 미용 치료에 대한 수요가 전염병 이후 크게 증가함에 따라 시장은 회복세를 보일 것으로 예상됩니다. 이는 주로 가상 만남 증가, 가처분 소득 증가, 소셜 미디어에 대한 높은 영향력, 미적 외모를 개선하고자 하는 욕구 때문인 것으로 분석됩니다. 미국 성형외과학회(ASPS)에 따르면, 전염병으로 인해 미용 시술에 대한 수용도가 높아졌습니다고 합니다.

비수술적 라이노플라스틱 시장 보고서 하이라이트

• HA 필러 분야는 예측 기간 동안 시장을 독점할 것으로 예상되며, HA 필러는 생체 적합성과 심미적 장점으로 인해 가장 선호도가 높고 채택률이 높은 필러입니다.
• 경미한 코 비대칭 응용 휠체어 부문은 유전이나 경미한 부상으로 인한 경미한 코의 편차가 세계 인구에 널리 퍼져있을 것으로 예상되기 때문에 예측 기간 동안 빠른 성장을 보일 것으로 예상됩니다.
• 메디컬 스파의 최종 용도 부문은 이러한 시설이 제공하는 종합적 인 서비스, 높은 접근성, 고급 제품 및 기술 채택, 비용 효율적인 치료의 가용성으로 인해 시장을 독점했습니다.
• 북미는 비침습적 미용 치료에 대한 높은 인식과 주요 기업의 존재로 인해 2022년 가장 높은 매출 점유율을 차지할 것으로 예상됩니다.
• 아시아태평양은 아시아 국가들의 미용 치료에 대한 인식과 채택이 증가함에 따라 예측 기간 동안 CAGR 8.8%로 성장할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 비수술 코성형 업계 전망

• 시장 세분화와 범위
• 시장 규모와 성장 전망
• 비수술 코성형 시장 - 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장이 해결해야 할 과제 분석
• 비수술 코성형 시장 - Porter의 Five Forces 분석
• 비수술 코성형 시장 - PESTEL 분석

제4장 비수술 코성형 : 용도 전망

• 용도별 비수술 코성형 시장 점유율, 2021년
• Indentations of dorsal hump
• Convex
• Minor Nasal Asymmetry
• 기타

제5장 비수술 코성형 : 필러 유형 전망

• 필러 유형별 비수술 코성형 시장 점유율, 2021년
• 히알루론산 필러
• CaHa 필러

제6장 비수술 코성형 : 최종 용도 전망

• 최종 용도별 비수술 코성형 시장 점유율, 2021년
• 메디컬 스파
• 병원/수술센터
• 의료 종사자 소유 클리닉

제7장 비수술 코성형 : 지역 전망

• 지역별 비수술 코성형 시장 점유율, 2021년
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근 동향과 영향 분석
• 벤더 구도
• 기업 개요
  • SKINovative of Gilbert-Medical Spa
  • The London Cosmetic Clinic
  • The Laser Skin Clinic
  • Therapie Clinic
  • VIVA Skin Clinic.
  • Toronto Cosmetic Clinic(TCC)
  • Piedmont Plastic Surgery &Dermatology
  • Toronto Cosmetic Clinic(TCC)
  • Skin Vitality Medical Clinic
  • Nova Aesthetic Clinic

LSH

영문 목차

영문목차

Non-surgical Rhinoplasty Market Growth & Trends:

The global non-surgical rhinoplasty market size is expected to reach USD 1.3 billion by 2030, registering a CAGR of 8.1% according to a new report by Grand View Research, Inc.. Non-surgical rhinoplasty, also known as liquid rhinoplasty is a non-invasive cosmetic procedure used to alter the shape and define a person's nose by using injectable fillers such as hyaluronic acid fillers. This method offers immediate results, no downtime, is less invasive, and is inexpensive. All these factors are expected to fuel the growth of the market.

Non-surgical rhinoplasty can be done in case a person has a dorsal bump, asymmetrical shape of the nose, dip in the nose bridge, improve/camouflage deformities, or treat mildly crooked nose. However, this procedure is only carried out to smooth out nasal imperfections and fix minor symmetry issues and cannot treat major nasal defects.

Injectable fillers like HA fillers and CaHa fillers are most commonly used in liquid Rhinoplasty procedures. However, as per Medical News Today, HA injectables are widely preferred and adopted by plastic surgeons and this is because these fillers are biocompatible, have a natural feel, provide a defined shape and complications can be reversed using hyaluronidase injection.

The market witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. However, it is expected to witness a recovery as the demand for non-invasive aesthetic treatments saw significant growth post-pandemic. This is majorly due to increased virtual meets, increased disposable income, high social media impact, and desirability to improve aesthetic appearance. According to the American Society of Plastic Surgeons (ASPS), the pandemic led to an increase in the acceptance of cosmetic procedures

Non-surgical Rhinoplasty Market Report Highlights:

• The HA filler segment is projected to dominate the market throughout the forecast period. It is the most preferred and highly adopted filler due to its biocompatibility and aesthetic benefits
• The minor nasal asymmetry application wheelchairs segment is projected to witness rapid growth over the forecast period as slight nasal misalignment due to genetics or minor injuries is expected to be prevalent in the global population
• The MedSpa end-use segment dominated the market owing to comprehensive services offered by such facilities, high accessibility, adoption of advanced products and technology as well as the availability of cost-effective treatments
• North America accounted for the highest revenue share in 2022 due to high awareness about non-invasive aesthetic treatment and the presence of major key players
• Asia Pacific is expected to grow at a CAGR of 8.8% over the forecast period, owing to the rising awareness and adoption of cosmetic treatments in Asian countries

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Research Methodology
• 1.2 Research Scope and Assumptions
• 1.3 List of Data Sources

Chapter 2 Executive Summary

• 2.1 Non-Surgical Rhinoplasty Market - Industry Snapshot, 2018 - 2030
• 2.2 Global Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 2.2.1 Global Non-Surgical Rhinoplasty market, by region, 2018 - 2030
  • 2.2.2 Global Non-Surgical Rhinoplasty market, by Application, 2018 - 2030
  • 2.2.3 Global Non-Surgical Rhinoplasty market, by Filler Type, 2018 - 2030
  • 2.2.4 Global Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030

Chapter 3 Non-Surgical Rhinoplasty Industry Outlook

• 3.1 Market Segmentation and Scope
• 3.2 Market Size and Growth Prospects
• 3.3 Non-Surgical Rhinoplasty Market - Market Dynamics
  • 3.3.1 Market driver analysis
  • 3.3.2 Market challenge analysis
• 3.4 Non-Surgical Rhinoplasty Market - Porter's Five Forces Analysis
• 3.5 Non-Surgical Rhinoplasty Market - PESTEL Analysis

Chapter 4 Non-Surgical Rhinoplasty Application Outlook

• 4.1 Non-Surgical Rhinoplasty Market Share By Application Type, 2021
• 4.2 Indentations of dorsal hump
  • 4.2.1 Indentation Market, 2018 - 2030
• 4.3 Convex
  • 4.3.1 Convex Nose Nose Market, 2018 - 2030
• 4.4 Minor Nasal Asymmetry
  • 4.4.1 Minor Nasal Asymmetry Market, 2018 - 2030
• 4.5 Others
  • 4.5.1 Others Market, 2018 - 2030

Chapter 5 Non-Surgical Rhinoplasty Filler Type Outlook

• 5.1 Non-Surgical Rhinoplasty Market Share By End Use, 2021
• 5.2 Hyaluronic Acid Fillers
  • 5.2.1 Hyaluronic Acid Market, 2018 - 2030
• 5.3. CaHa Fillers
  • 5.3.1. CaHa Market, 2018 - 2030

Chapter 6 Non-Surgical Rhinoplasty End-Use Outlook

• 5.1 Non-Surgical Rhinoplasty Market Share Application, 2021
• 6.2 MedSpa
  • 6.2.1 Irregular Edges Incisors Market, 2018 - 2030
• 6.3. Hospital/Surgery Center
  • 6.3.1. Hospital/Surgery Center Market, 2018 - 2030
• 6.4 HCP-owned clinic
  • 6.4.1 HCP-owned clinic Market, 2018 - 2030

Chapter 7 Non-Surgical Rhinoplasty Regional Outlook

• 7.1 Non-Surgical Rhinoplasty Market Share By Region, 2021
• 7.2 North America
  • 7.2.1 North America Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.2.2 North America Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.2.3 North America Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.3 U.S.
  • 7.3.1 U.S. Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.3.2 U.S. Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.3.3 U.S. Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.4 Canada
  • 7.4.1 Canada Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.4.2 Canada Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.4.3 Canada Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.5 Europe
  • 7.5.1 Europe Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.5.2 Europe Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.5.3 Europe Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.6 Germany
  • 7.6.1 Germany Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.6.2 Germany Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.6.3 Germany Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.7. U.K.
  • 7.7.1 U.K. Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.7.2 U.K. Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.7.3 U.K. Non-Surgical Rhinoplasty market, by end-use, 2018 - 2030
• 7.8. France
  • 7.8.1 France Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.8.2 France Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.8.3 France Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.9. Italy
  • 7.9.1 Italy Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.9.2 Italy Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.9.3 Italy Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.10. Spain
  • 7.10.1 Spain Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.10.2 Spain Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.10.3 Spain Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.11 Asia Pacific
  • 7.11.1 Asia Pacific Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.11.2 Asia Pacific Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.11.3 Asia Pacific Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.12 China
  • 7.12.1 China Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.12.2 China Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.12.3 China Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.13 India
  • 7.13.1 India Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.13.2 India Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.13.3 India Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.14 Japan
  • 7.14.1 Japan Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.14.2 Japan Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.14.3 Japan Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.15 Thailand
  • 7.14.1 Thailand Non-surgical Rhinoplasty market By application, 2018 - 2030
  • 7.14.2 Thailand Non-surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.14.3 Thailand Non-surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.16 South Korea
  • 7.16.1 South Korea Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.16.2 South Korea Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.16.3 South Korea Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.17 Latin America
  • 7.17.1 Latin America Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.17.2 Latin America Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.17.3 Latin America Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.18 Brazil
  • 7.18.1 Brazil Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.18.2 Brazil Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.18.3 Brazil Non-Surgical Rhinoplasty market, by end-use, 2018 - 2030
• 7.19 Mexico
  • 7.19.1 Mexico Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.19.2 Mexico Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.19.3 Mexico Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.20 Argentina
  • 7.20.1 Argentina Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.20.2 Argentina Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.20.3 Argentina Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.21 MEA
  • 7.21.1 MEA Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.21.2 MEA Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.21.3 MEA Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.22 South Africa
  • 7.22.1 South Africa Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.22.2 South Africa Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.22.3 South Africa Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.23 Saudi Arabia
  • 7.23.1 Saudi Arabia Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.23.2 Saudi Arabia Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.23.3 Saudi Arabia Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030
• 7.24 UAE
  • 7.24.1 UAE Non-Surgical Rhinoplasty market By application, 2018 - 2030
  • 7.24.2 UAE Non-Surgical Rhinoplasty market, by Filler Type 2018 - 2030
  • 7.24.3 UAE Non-Surgical Rhinoplasty market, by End Use, 2018 - 2030

Chapter 8 Competitive Landscape

• 8.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 8.1.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 8.1.2 PARTICIPANT CATEGORIZATION
    • 8.1.1.1 INNOVATORS
• 8.2 Vendor Landscape
  • 8.2.1 List of Key Service Providers
  • 8.2.2 Heat Map Analysis
• 8.3 Company Profiles
  • 8.3.1 SKINovative of Gilbert - Medical Spa
    • 8.3.1.1 Company overview
    • 8.3.1.2 Financial performance
    • 8.3.1.3 Service benchmarking
    • 8.3.1.4 Strategic initiatives
  • 8.3.2 The London Cosmetic Clinic
    • 8.3.2.1 Company overview
    • 8.3.2.2 Financial performance
    • 8.3.2.3 Service benchmarking
    • 8.3.2.4 Strategic initiatives
  • 8.3.3 The Laser Skin Clinic
    • 8.3.3.1 Company overview
    • 8.3.3.2 Financial performance
    • 8.3.3.3 Service benchmarking
    • 8.3.3.4 Strategic initiatives
  • 8.3.4 Therapie Clinic
    • 8.3.4.1 Company overview
    • 8.3.4.2 Financial performance
    • 8.3.4.3 Service benchmarking
    • 8.3.4.4 Strategic initiatives
  • 8.3.5 VIVA Skin Clinic.
    • 8.3.5.1 Company overview
    • 8.3.5.2 Financial performance
    • 8.3.5.3 Service benchmarking
    • 8.3.5.4 Strategic initiatives
  • 8.3.6 Toronto Cosmetic Clinic (TCC)
    • 8.3.6.1 Company overview
    • 8.3.6.2 Financial performance
    • 8.3.6.3 Service benchmarking
    • 8.3.6.4 Strategic initiatives
  • 8.3.7 Piedmont Plastic Surgery & Dermatology
    • 8.3.7.1 Company overview
    • 8.3.7.2 Financial performance
    • 8.3.7.3 Service benchmarking
    • 8.3.7.4 Strategic initiatives
  • 8.3.8 Toronto Cosmetic Clinic (TCC)
    • 8.3.8.1Company overview
    • 8.3.8.2 Financial performance
    • 8.3.8.3 Service benchmarking
    • 8.3.8.4 Strategic initiatives
  • 8.3.9 Skin Vitality Medical Clinic
    • 8.3.9.1 Company overview
    • 8.3.9.2 Financial performance
    • 8.3.9.3 Service benchmarking
    • 8.3.9.4 Strategic initiatives
  • 8.3.10 Nova Aesthetic Clinic
    • 8.3.10.1 Company overview
    • 8.3.10.2 Financial performance
    • 8.3.10.3 Service benchmarking
    • 8.3.10.4 Strategic initiatives

관련자료